Physician

Michael A Behforouz, MD

According to 2025 Medicare claims, Michael Behforouz, MD (NPI: 1942283288) practices ophthalmology in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Hamilton, IN. This provider's primary affiliated billing organization is MIDWEST CENTER FOR SIGHT, LLC (NPI: 1710096300; TIN: 71-0943164) and primary practice location at 46032-7779.

Behforouz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,284 traditional Medicare patients, billed 12,470 HCPCS/CPT codes, and received $1,385,284 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,199 prescription claims across 758 beneficiaries totaling $277,037 in drug costs, led by Restasis (Cyclosporine). 2017 DME data shows 14 claims. Open Payments data shows 75 records totaling $1,783. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $585,821 to $1,385,284. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,707	6,143	$585,821
2016	1,839	7,149	$653,382
2017	2,106	7,690	$771,674
2018	2,204	8,769	$854,074
2019	2,350	9,835	$1,119,596
2020	2,106	8,771	$868,759
2021	2,122	9,073	$1,002,312
2022	1,756	7,577	$952,342
2023	1,540	9,329	$1,003,327
2024	1,284	12,470	$1,385,284

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	624	2,864	$327,712
2016	721	3,423	$402,799
2017	770	3,543	$483,125
2018	807	3,741	$504,638
2019	873	3,795	$563,147
2020	821	3,518	$534,161
2021	799	2,963	$509,593
2022	779	2,542	$476,157
2023	731	2,374	$550,221
2024	758	2,199	$277,037

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	14	14	$739
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	508	509	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	345	498	$58
92136	Measurement of corneal curvature and depth of eye	315	511	$28
92134	Imaging of retina	413	855	$27
92025	Ct scan of cornea	321	425	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	46	2,885	$54,312
Ilevro	Nepafenac	81	2,518	$31,454
Prednisolone Acetate	Prednisolone Acetate	468	15,291	$27,641
Lumigan	Bimatoprost	50	2,640	$24,898
Xiidra	Lifitegrast	12	660	$14,899

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,783	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael A. Behforouz, MD?

Tedicare shows public-source Medicare data for Michael A. Behforouz, MD (NPI 1942283288), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Behforouz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael A. Behforouz, MD?

Michael A. Behforouz, MD is linked to MIDWEST CENTER FOR SIGHT, LLC (billing NPI 1710096300) in the available physician profile data.

Does Michael A. Behforouz, MD have Open Payments data?

Michael A. Behforouz, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.